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Endocannabinoids (eCBs) modulate a variety of brain functions via activation of the widely expressed CB1
receptor. One site of high density of this receptor is the basolateral amygdala (BLA), a structure involved
in the formation of aversive memories. The activation and blockade of CB1 receptors by systemic or hip-
pocampal drug administrations have been shown to modify memory processing. However, little is known
about the role of the BLA endocannabinoid system in aversive memories. Additionally, BLA endocannab-
inoid transmission seems to be related to emotional states, but the relevance of these effects to memory
formation is still unknown. In this study we investigated the effects of the eCB anandamide (AEA) and the
CB1 antagonist/inverse agonist AM251 infused into the BLA on the acquisition of an aversive memory
task, concomitantly evaluating basal anxiety levels in rats. Male rats received pre-training micro-injec-
tion of AEA, AM251 or vehicle bilaterally into the BLA, and were studied with the plus-maze discrimina-
tive avoidance task (a paradigm that allows concomitant and independent evaluation of anxiety-like
behavior and the memory of an aversive task). Our results showed that AEA into the BLA before training
prevented memory retrieval 24 h later, as evaluated by exploration of the aversive arm of the maze, while
AM251 into the BLA did not interfere with animals’ performance. In addition, AEA had no effect on anx-
iety-like behavior (as evaluated by open arm exploration and risk assessment), while AM251 induced an
anxiogenic effect. Our data indicate an important role of BLA CB1 receptors in aversive memory forma-
tion, and suggest that this involvement is not necessarily related to a possible modulation of anxiety
states.
 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction learning and memory (Ameri, 1999; Freund et al., 2003). In that re-Endocannabinoids (eCBs), represented by the two main com-
pounds anandamide (AEA) and 2-arachidonoylglycerol (2-AG),
are endogenous lipids produced on demand that act as retrograde
messengers through the activation of the cannabinoid receptors
CB1 (Alger, 2002). CB1 receptors are Gi-protein-coupled receptors
whose activation has shown to decrease neuronal excitability
and neurotransmitter release (Freund, Katona, & Piomelli, 2003).
They are widely distributed in the central nervous system (Herken-
ham et al., 1991), mainly in the basal ganglia, cerebellum, neocor-
tex, hippocampus (Bisogno et al., 1999; Herkenham et al., 1991),
pre-frontal cortex and amygdala (Katona, Rancz, & Acsady, 2001;
McDonald & Mascagni, 2001).
The endocannabinoid system has been shown to participate in a
variety of brain functions, such as pain, locomotion, feeding, and, anandamide; BLA, basolat-
de Fisiologia – Centro de
stal 1511, CEP 59078-970 –
a).
sevier OA license.gard, eCBs have emerged as important modulators of memory pro-
cessing (Heifets & Castillo, 2009) although the exact mechanisms
underlying this regulation are not completely understood. Indeed,
systemic blockade of CB1 receptors in rodents has either failed to
affect memory acquisition (Hampson & Deadwyler, 1998;
Marsicano et al., 2002) or induced memory improvement
(Lichtman, 2000; Takahashi, Pamplona, & Fernandes, 2005).
Conversely, pre-training systemic administration of CB1 receptor
agonists has shown to impair memory performance in rats (Fride,
2005; Hampson & Deadwyler, 1998; Lichtman & Martin, 1996).
The participation of the eCBs within speciﬁc brain regions on
memory modulation has recently started to be elucidated. It has
been observed, for example, that intra-hippocampal pre-training
infusions of either AM251, a CB1 receptor antagonist/inverse ago-
nist, or AEA did not inﬂuence acquisition of the step-down inhibi-
tory avoidance task (de Oliveira Alvares, Genro, Diehl, & Quillfeldt,
2008). Nevertheless, AM251 micro-injections into the medial pre-
frontal cortex blocked learning of an olfactory fear-conditioning
procedure, while CB1 receptor activation enabled associative
learning when a subthreshold level of footshock was applied
(Laviolette & Grace, 2006). Moreover, it has been suggested that
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activation or blockade could be related to the emotional salience
of the sensory stimuli of the task. In this respect, while non-aver-
sive memories do not seem to be regulated by the endocannabi-
noid system (de Oliveira Alvares et al., 2006; Hölter et al., 2005;
Niyuhire et al., 2007; Pamplona & Takahashi, 2006), strong
evidences support the involvement of this system on memory
processing for emotional stimuli (Viveros, Marco, Llorente, &
López-Gallardo, 2007). This idea is further supported by the fact
that the amygdala, known for its crucial role in associating
emotionally charged stimuli (for a review Phelps & LeDoux,
2005), presents high CB1 receptors density (Katona et al., 2001;
McDonald & Mascagni, 2001) and also exhibits increased levels
of AEA and 2-AG after presentation of stress and aversive stimuli
(Marsicano et al., 2002; Rademacher et al., 2008).
The amygdala has been divided into various cytoarchitecturally
and functionally distinct nuclei, being the complex of the basolat-
eral amygdala (BLA) one of the main regions responsible for inte-
grating sensory inputs and modulating emotions, as well as
acquisition and expression of emotional memories (Maren,
Aharonov, & Fanselow, 1996; Phelps & LeDoux, 2005). BLA outputs
have shown to be related to the induction of a variety of endocrine
and emotional responses (Pitkanen, Savander, & LeDoux, 1997) by
regulating the hypothalamus–pituitary–adrenal (HPA) axis during
responses to anxiety and fear (LeDoux, 2000). In this respect, re-
cent research from Ganon-Elazar and Akirav (2009) has shown that
infusion of a CB1 agonist into the BLA before exposure to a stressor
has reversed the stress-induced memory enhancement and de-
creased corticosterone levels in rats.
Besides modulating emotional memory formation, the eCBs
have also been shown to play an important role in the control
and regulation of anxiety states (Lutz, 2009; Viveros et al., 2007).
This idea is supported by studies showing that systemic adminis-
tration of a cannabinoid antagonist induces anxiety-like responses
in rats (Navarro et al., 1997), along with CB1 receptor knockout
(KO) mice studies reporting increased anxiety-like behaviors in a
variety of tests (Uriguen, Perez-Rial, Ledent, Palomo, & Manzan-
ares, 2004). Conversely, systemic studies enhancing CB1 receptors
activation have shown biphasic effects, with low doses being anx-
iolytic (Kathuria et al., 2003) and high doses, anxiogenic (Scherma
et al., 2008). Yet, a recent study has observed that, depending on
the structure, activation of the endocannabinoid system may have
different effects upon anxiety modulation (Rubino et al., 2008). In
that respect, it is important to note that although the endocannab-
inoid transmission within the BLA seems to be related to emotional
states, the relevance of this relationship to endocannabinoid effects
on memory is still unknown.
In view of the fact that the BLA contains not only more CB1
receptors, but also more abundant CB1 mRNA compared to the
other amygdalar nuclei (Katona et al., 2001) and also plays an
important role in the modulation of emotional behaviors (Davis,
Rainnie, & Cassell, 1994; Maren, Aharonov, & Fanselow, 1996),
the present study investigated the effects of intra-BLA pre-training
infusions of AEA or AM251 in the plus-maze discriminative avoid-
ance task in order to simultaneously evaluate anxiety-like behav-
ior, learning and memory (Silva & Frussa-Filho, 2000).2. Material and methods
2.1. Subjects
Three-month-old male Wistar rats (250–300 g) were housed
under conditions of controlled temperature (20–23 C) under a
12 h light/12 h dark (lights on 06:30 am). Animals were housed
in groups of 4–5 until surgery, when they were individuallyhoused. Food and water were available ad libitum throughout the
experiment. Rats were handled in accordance with the guidelines
of the Brazilian Society for Neuroscience and Behavior for the use
of animals in research, and all procedures were approved by the lo-
cal ethical committee. All efforts were made to minimize animal
pain, suffering or discomfort.
2.2. Surgery
Rats were anesthetized with ketamine and xylazine (i.p., 100
and 50 mg/kg, respectively) and two 23-gauge stainless-steel guide
cannulae were bilaterally implanted into the BLA. The coordinates
were AP 2.8 mm from bregma, LL ±4.9 mm, DV-6.4 mm (2.0 mm
above BLA), according to Paxinos and Watson (2009). The cannulae
were permanently ﬁxed to the skull with dental acrylic and two
stainless-steel screws. To prevent clogging, a stainless-steel stylus
(30-gauge) was inserted into the guide cannulae and kept until the
time of infusion. After surgery, each rat was individually housed
and a recovery period of 5–7 days was given before testing. After
two days of recovery, each animal was handled 10 min once a
day until the day of the experiment.
2.3. Drugs and administration
AM251, a CB1 receptor antagonist/inverse agonist (Pertwee,
2006), and AEA, an endogenous cannabinoid, from Tocris Biosci-
ence, were dissolved in a vehicle solution of 8% dimethylsulfoxide
(DMSO) in phosphate buffered saline. Vehicle (DMSO 8%, n = 11),
AM251 (10 ng per side, n = 10) or AEA (1 ng per side, n = 9) were
infused bilaterally in the BLA in a volume of 0.2 lL at a rate of
0.1 lL/min via a microsyringe pump using Hamilton syringes con-
nected to polyethylene tubing. Infusions were given 15 min before
training session of the behavioral task. The concentrations and
interval of injections chosen have been shown to be effective in
the hippocampus (de Oliveira Alvares et al., 2008) and similarly
in the BLA (Ganon-Elazar & Akirav, 2009). The infusion cannulae
were left for 1 min more to allow total diffusion.
2.4. Plus-maze discriminative avoidance task (PM-DAT)
The PM-DAT is an aversive task paradigmwhich allows the con-
comitant and independent evaluation of aversive memory and
anxiety-like behavior in rodents (Ribeiro et al., 2010; Silva & Frus-
sa-Filho, 2000). The apparatus employed was a modiﬁed plus-
maze, containing two open arms (49  13 cm) opposite to two en-
closed arms (49  13  40 cm). A lamp and two loudspeakers were
placed over one of the enclosed arms (aversive enclosed arm). In
the training session, each rat was individually placed in the center
of the apparatus (facing the space between both open arms) and,
over a period of 10 min, every time the animal entered with the
four paws in the aversive enclosed arm, the aversive stimuli were
given until the animal left it. The aversive stimuli were the light
(100W, 600 lx) and a digitally produced 80 dB noise. Test session
was performed 24 h after the conditioning, during which the ani-
mals were again placed in the apparatus for 3 min, without receiv-
ing the aversive stimulation.
Both sessions (training and test) were performed in the same
room with a controlled intensity of light. On each side of the
plus-maze discriminative avoidance apparatus there were differ-
ent extra-maze visual cues that rats could use to distinguish the
location of the different arms of the maze. All behavioral sessions
were recorded using a camera ﬁxed on the ceiling above the appa-
ratus. During both sessions, behavior was tracked and registered
by the Any-Maze software (Stoelting), and an observer monitored
the session by a computer screen placed at another room. After
each session, the apparatus was cleaned with 5% alcohol solution.
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spent in the aversive enclosed arm [(time spent in the aversive en-
closed arm/time spent in both enclosed arms)  100] throughout
the training session. Memory was evaluated by the percent time
spent in the aversive enclosed arm in the test session, as well as
the discrimination between the aversive and non-aversive en-
closed arms. Anxiety-like behavior was evaluated by the percent
time spent in the open arms [(time spent in open arms/time spent
in both open and enclosed arms)  100)], percentage of entries in
the open arms [(open arms entries/total entries in all arms)  100]
and time performing risk assessment, which consists of postures
and behaviors performed by the rodents when evaluating/avoiding
the open arms (Carobrez & Bertoglio, 2005). Distance traveled was
used to evaluate motor activity.2.5. Histology
After behavioral procedures, rats were anesthetized with thio-
pental and perfused intracardially with phosphate-buffered saline
(PBS) with NaCl 0.9% (pH 7.4), followed by 4.0% paraformaldehyde
in 1.0 M PBS. Injection sites were marked by microinjection of
methylene blue (0.2 lL per side) into the guide cannulae. Brains
were removed and postﬁxed for two days in a 4.0% paraformalde-
hyde solution and then were put in sucrose 30% for 2–3 days. All
brains were sectioned on a microtome and sections (100 lm) were
stained with Neutral red. The location of cannulae tips was micro-
scopically veriﬁed using the coordinates and limits deﬁned by Pax-
inos and Watson (2009). Only rats with both cannulae tips within
the boundaries of BLA were included in the data analysis (Fig. 1).2.6. Statistical analysis
Percent time throughout the training session was compared by
two-way analysis of variance (ANOVA) with treatment as a be-
tween subject factor and time (minutes of observation) as a re-
peated measure. Distance traveled, percentage of time spent in
the aversive enclosed arm, percent time spent in open arms, per-
centage of entries in the open arms and risk assessment were com-
pared by the one-way ANOVA followed by Bonferroni’s test. The
discrimination between the aversive and non-aversive enclosed
arms was compared by the paired samples Student’s t-test. A prob-Fig. 1. (A) Schematic drawing illustrating the injection cannulae placement for rat
microphotography showing the injector cannula mark.ability of p < 0.05 was considered to show signiﬁcant differences
for all comparisons made.
3. Results
3.1. Learning and memory
In the training session, two-way ANOVA, revealed a time effect
for the percent time spent in the aversive arm [F(9,243) = 20.66,
p < 0.001] but no treatment effect [F(2,27) = 0.65, p = 0.53] or treat-
ment x time interaction [F(18,243) = 0.66, p = 0.84]. This result
indicates that all groups learned the task, as seen by the decrease
in percent time spent in the aversive arm throughout the training
session (Fig. 2A). One-way ANOVA considering the whole training
session revealed no difference among groups [F(2,27) = 0.52,
p = 0.6] (Fig. 2B).
In the test session, as shown in Fig. 2C, one-way ANOVA fol-
lowed by Bonferroni’s test revealed that the group receiving AEA
showed increased percent time spent in the aversive arm when
compared to control [F(2,27) = 4.3, p = 0.02], suggesting that pre-
training micro-infusion of AEA into the BLA caused memory
impairment. The AM251 group showed no differences when com-
pared to control group. Accordingly, when discrimination between
the enclosed arms (aversive arm vs. non-aversive arm, Fig. 2D) was
analyzed, vehicle and AM251-treated groups spent signiﬁcantly
more time in the non-aversive arm [(t = 4.52, p = 0.001), (t = 4.03,
p = 0.003), respectively], indicating memory retrieval, whereas
AEA-treated animals showed no discrimination between enclosed
arms (t = 1.14, p = 0.29).
3.2. Anxiety-like behavior
When the percent time spent in the open arms during the
whole session were evaluated, no differences were found among
the groups [F(2,27) = 1.53, p = 0.24 – Fig. 3A]. On the other hand,
as shown in Fig. 3B, one-way ANOVA for the percentage of entries
in the open arms during the whole training session revealed a dif-
ference among the groups [F(2,27) = 4.44, p = 0.02]. However, post
hoc analysis with Bonferroni’s test did not reach signiﬁcance,
although suggesting that AM251-treated animals showed in-
creased anxiety-like behavior (decreased open-arm entries) when
compared to control group.s included in statistical analysis (Paxinos & Watson, 2009). (B) Representative
Fig. 2. Effects of pre-training micro-injection of AM251 or AEA in the BLA on learning (A and B) and retrieval (C and D) of discriminative avoidance task in rats (VEH, n = 11;
AM251, n = 10; AEA, n = 9). Mean ± S.E. for (A) percent time spent in the aversive arm throughout training session (two-way ANOVA with repeated measures, revealing time
effect, (B) percent time spent in the aversive enclosed arm (TAv) during the whole training, (C) percent time spent in the aversive enclosed arm during test session and (D)
percent time spent in each of the enclosed arms (TAv and TNAv) during test session. #p < 0.05 compared to vehicle; ⁄p < 0.01 compared to TAv (paired samples t-test).
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was also evaluated (Fig. 3C), since it has been suggested that this
parameter would be a more sensitive measure of anxiety-like
behavior than the traditional measures (Carobrez & Bertoglio,
2005). During training session, one-way ANOVA for risk assessment
showed a signiﬁcance difference [F(2,27) = 3.61, p = 0.04] with post
hoc indicating an anxiogenic effect of AM251 (p = 0.04), seen by a
reduction of the time performing risk assessment.
One-way ANOVA revealed no differences between the groups
when evaluating the percent time spent in the open arms
(Fig. 3A), percentage of entries in the open arms (Fig. 3B) or risk
assessment (Fig. 3C) during test session [F(2,27) = 0.37, p = 0.58;
F(2,27) = 0.87, p = 0.43; F(2,27) = 0.5, p = 0.61, respectively].3.3. Locomotion
No differences were found in distance traveled during training
[F(2,27) = 1.28, p = 0.29] or test [F(2,27) = 1.26; p = 0.3] sessions
(Table 1).4. Discussion
In summary, our results showed that (1) during training session,
all groups learned the task by progressively avoiding the aversive
arm throughout the session (Fig. 2A and B); (2) AEA given before
training into the BLA disrupted memory formation – shown by
the lack of discrimination between the two enclosed arms in the
test session, whereas AM251 did not interfere with memory for-mation (Fig. 2C and D); and (3) AM251 into the BLA induced an
anxiogenic effect – shown by the reduced percentage of entries
in the open arms and risk assessment during training, while AEA
had no effects on anxiety levels (Fig. 3).
Endocannabinoid release has been shown to occur in the amyg-
dala when animals are exposed to stressful stimuli (Marsicano
et al., 2002; Rademacher et al., 2008). As acquisition of a new aver-
sive memory evidently requires an unpleasant emotional context,
it is possible that eCBs are recruited during acquisition of emo-
tional-charged information, in order to reduce the stress-induced
arousal, as proposed by Lutz (2009). It is widely accepted that
the amygdala plays a crucial role in acquisition of aversive memo-
ries. In humans, it is known to be recruited during early phases of
aversive conditioning (LaBar, Gatenby, Gore, LeDoux, & Phelps,
1998). Similarly, several animal studies show impaired acquisition
of aversive memory after BLA inactivation (for a review see Phelps
& LeDoux, 2005). In this respect, there is evidence that canabin-
noids not only alter BLA function by reducing neuronal ﬁring rates
(Pistis et al., 2004), but also induce long-term depression (LTD) at
excitatory synapses (Marsicano et al., 2002). It has also been shown
that infusion of the cannabinoids THC and CP55940 in the hippo-
campus disrupted the temporal coordination of cell assemblies
and impaired physiological oscillations, being this impairment
associated with memory deﬁcits (Robbe et al., 2006).
In the present study, although successful conditioning was
shown by all groups, it is possible that the weak fearful nature of
non-painful stimuli would require the BLA to integrate the differ-
ent sensory inputs (LeDoux, 1990; Turner, 1981) further needed
for subsequent memory consolidation. Therefore, the disrupted re-
Fig. 3. Effects of pre-training micro-injection of AM251 or AEA in the BLA on anxiety-like behavior in discriminative avoidance task in rats (VEH, n = 11; AM251, n = 10; AEA,
n = 9). Mean ± S.E. for (A) percent time spent in the open arms, (B) percent of entries in the open arms and (C) time performing risk assessment during training session.
⁄p < 0.05 compared to vehicle.
Table 1
Effects of pre-training micro-injection of vehicle, AEA or AM251 in the BLA on
locomotion in discriminative avoidance apparatus in rats (VEH, n = 11; AM251,
n = 10; AEA, n = 9). Mean ± S.E. for distance traveled (m) in the training and test
sessions. No signiﬁcant differences were found (one-way ANOVA).
Training Test
Distance Vehicle 13.7 ± 2.2 4.6 ± 0.8
AM251 8.8 ± 1.7 4.1 ± 0.8
AEA 12.9 ± 3.1 5.9 ± 1.1
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to amygdala dysfunction during training, with consequent loss of
its capacity to recognize and integrate cues of threat and danger
(Adolphs, Tranel, & Damasio, 1998), leading to inefﬁcient aversive
stimuli processing and memory formation.
On the other hand, because micro-infusions have been given be-
fore training, drugs would remain acting after training session and
could modulate memory consolidation as it takes place during the
ﬁrst hours after training (Izquierdo et al., 2006; McGaugh, 2000).
However, Campolongo and collaborators et al. (2009) have recently
shown that post-training micro-injection of WIN-55,212-2, a CB1
receptor agonist, within the BLA has, in fact, improved memory
consolidation of inhibitory avoidance task. Thus, although different
task and CB1 agonist were used in the present study, the memory
deﬁcit following AEA administration in the BLA before training is
most likely related to a disruption in BLA function during the
acquisition of the information rather than an action during subse-
quent memory consolidation.
Corroborating the present data, Phan and collaborators (2008)
have recently reported reduced amygdala reactivity to threatening
stimuli after an acute dose of THC in humans. Furthermore, a re-
cent fMRI study proposed that amygdala interactions with other
brain regions would enhance memory formation by increasingattention and perceptual processing of emotional information
(Murty, Ritchey, Adcock, & Labar, 2010), which is in accordance
with several human studies showing attention deﬁcits (Curran,
Brignell, Fletcher, Middleton, & Henry, 2002; Marks & MacAvoy,
1989), as well as memory impairments (Curran et al., 2002; Lew-
eke et al., 1998; Ranganathan & D’Souza, 2006) after acute THC
consumption.
In the present study, blockade of CB1 receptors with AM251
within the BLA did not interfere with memory formation. Accord-
ingly, some studies with systemic CB1 antagonist administrations
were also unsuccessful in modulating memory acquisition (Hamp-
son & Deadwyler, 2000; Marsicano et al., 2002) although others
have shown an enhancement on memory acquisition (Lichtman,
2000; Takahashi et al., 2005). Moreover, a recent study showed
that AM251 in the BLA (5 and 50 ng) was not sufﬁcient to alter
acquisition of conditioned fear memories (Tan, Lauzon, Bishop,
Bechard, & Laviolette, 2010). On the other hand, comparing the ef-
fects of AM251 (CB1 antagonist/inverse agonist) with AM4113
(CB1 antagonist) on contextual fear conditioning, Sink, Segovia,
Collins et al. (2010) showed that systemic administration of
AM251 before conditioning increased memory formation, while
AM4113 had no effects, suggesting that the effects of AM251 could
be speciﬁcally related to its inverse agonist activity. Nevertheless,
although only AM251 was tested in the present study, it seems that
the blockade of CB1 receptors in the BLA would not alter plus-maze
discriminative avoidance acquisition despite the activation of
these receptors by AEA would impair it. In this respect, it is impor-
tant to note that CB1 receptor activation is not the only mechanism
of action of AEA (Pertwee, 2006). This eCB also targets, for example,
the vanilloid receptor TRVP1 (Tognetto et al., 2001), as well as
potassium channels (Maingret, Patel, Lazdunski, & Honore, 2001),
and a possible role of these other mechanisms in the effect of
AEA on aversive memory could not be ruled out.
532 H. Munguba et al. / Neurobiology of Learning and Memory 95 (2011) 527–533As mentioned above, the endocannabinoid transmission is not
only involved in memory processing, being considered an impor-
tant modulator of emotional states (Lutz, 2009; Viveros et al.,
2007). Accordingly, knockout mice for CB1 receptors show in-
creased anxiety levels in several behavioral tasks (Haller, Bakos,
Szirmay, Ledent, & Freund, 2002; Uriguen et al., 2004) and in-
creased anxiety levels have also been reported after a systemic
CB1 receptor antagonist administration (Navarro et al., 1997).
Moreover, a systemic AM251 administration caused enhanced
c-Fos expression in the amygdala, which was also associated with
an anxiogenic effect (Sink, Segovia, Sink et al., 2010). In general, our
results corroborate those ﬁndings, since AM251 administration in
the BLA increased anxiety-like behavior (although a statistically
signiﬁcant difference was found only for one of the parameters
measured – see Fig. 3). Furthermore, Rubino and collaborators
(2008) have recently reported that THC at higher concentrations
in the BLA had no effects on anxiety levels, which is in line with
our results, since AEA did not alter anxiety-like behaviors. It has
also been seen that the GABAA agonist muscimol (which might
cause an inactivation of BLA neurons similar to AEA), when infused
within the BLA was also ineffective in altering anxiety levels of rats
submitted to the PM-DAT (Ribeiro et al., in press). In contrast, how-
ever, studies with systemic potentiation of the endocannabinoid
signaling have shown anxiolytic effects in low doses (Kathuria
et al., 2003), with higher doses being anxiogenic (Scherma et al.,
2008).
The mechanisms underlying the role of eCBs in the amygdala in
anxiety states is not completely understood. Interestingly, a high
co-localization has been observed in BLA GABAergic interneurons
containing CB1 receptors and the anxiogenic neuropeptide chole-
cystokinin (CCK) (Katona et al., 1999; Marsicano & Lutz, 1999;
McDonald & Mascagni, 2001). In addition, activation of CB1 recep-
tors has shown to reduce CCK release (Beinfeld & Connolly, 2001;
Burdyga et al., 2004; Fride, 2005). Higher CCK levels would, in turn,
excite BLA interneurons (Chung & Moore, 2009a), as well as en-
hance its GABAergic transmission (Chung & Moore, 2007).
Although it may be argued that this increase of GABAergic trans-
mission would in fact reduce BLA activity, leading to anxiolytic
states, it has been recently reported that CCK also excites glutama-
tergic projections in the BLA by modulation speciﬁc subsets of
interneurons (Chung & Moore, 2009b). Along with that idea, Truitt,
Johnson, Dietrich, Fitz, and Shekhar (2009) have shown that dis-
crete subpopulations of interneurons in the rat BLA are sufﬁcient
to modulate anxiety states.
Alternatively, corticosteroids have an important role in regulat-
ing anxiety states, as well as in response to stressful stimuli. In
accordance, glucocorticoids were shown to enhance BLA principal
neurons excitability (Duvarci & Pare, 2007), which could generate
anxiogenic effects (Davis et al., 1994). Recently, glucocorticoids
have been found to act together with the endocannabinoid system
in the modulation of stress responses (Hill et al., 2010; Patel,
Roelke, Rademacher, Cullinan, & Hillard, 2004), as well as memory
processing inﬂuenced by stressful factors (de Oliveira Álvares et al.,
2010) as would be the case of aversive memory tasks.
In summary, our data show that intra-amygdala AEA infused
before conditioning impaired memory formation for the discrimi-
native avoidance task, as seen by deﬁcient memory retrieval dur-
ing test. Although not discarding a possible interference with
subsequent memory consolidation, we propose that the enhance-
ment of AEA levels within the BLA may act on the acquisition of
aversive information by altering the integration of relevant sensory
inputs or even by impairing the evaluation of the threat nature of
the stimuli. Importantly, the antagonist/inverse agonist of CB1
receptors AM251 did not interfere with memory, inducing, how-
ever, an anxiogenic effect. Taken together, the ﬁndings presented
here suggest that, although drugs that act on the endocannabinoidsystem within the BLA may alter aversive memory as well as anx-
iety-like behaviors, these modulations do not seem to be necessar-
ily related, since alteration of anxiety-like states and memory
formation occurred independently in rats tested in the PM-DAT.Acknowledgments
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